Evaluation of ionotropic and chronotropic compounds in vitro using human ips-derived cardiomyocytes and impedance-based contractility assay

被引：0
|
作者：
Zhang, Xiaoyu [1 ]
Xi, Biao [1 ]
Wang, Xiaobo [1 ]
Xu, Xiao [1 ]
Abassi, Yama A. [1 ]
机构：
[1] Acea Biosci Inc, San Diego, CA 92121 USA
来源：
JOURNAL OF PHARMACOLOGICAL AND TOXICOLOGICAL METHODS | 2015年 / 76卷
关键词：
D O I：
10.1016/j.vascn.2015.07.005
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页码：96 / 96
页数：1
相关论文
共 50 条
  • [1] An Impedance-Based Cellular Assay Using Human iPSC-Derived Cardiomyocytes to Quantify Modulators of Cardiac Contractility
    Scott, Clay W.
    Zhang, Xiaoyu
    Abi-Gerges, Najah
    Lamore, Sarah D.
    Abassi, Yama A.
    Peters, Matthew F.
    [J]. TOXICOLOGICAL SCIENCES, 2014, 142 (02) : 331 - 338
  • [2] Simultaneous measurement of action potentials and contractility of human iPS-derived cardiomyocytes for safety assessment of pharmaceutical compounds
    Zhang, Xiaoyu
    Ouyang, Wayne
    Xi, Biao
    Xu, Xiao
    Wang, Xiaobo
    Abassi, Yama A.
    [J]. JOURNAL OF PHARMACOLOGICAL AND TOXICOLOGICAL METHODS, 2015, 75 : 168 - 168
  • [3] An application of human iPS-derived cardiomyocytes in cardiac safety screening assay
    Kurokawa, Junko
    Ashihara, Takashi
    Furukawa, Tetsushi
    Kanda, Yasunari
    [J]. JOURNAL OF PHARMACOLOGICAL SCIENCES, 2015, 128 (03) : S57 - S57
  • [4] Assessment of TdP risk using human iPS-derived cardiomyocytes by JiCSA 60 compounds
    Yamazaki, Daiju
    Ando, Hiroyuki
    Yoshinaga, Takashi
    Yamamoto, Wataru
    Asakura, Keiichi
    Taniguchi, Tomohiko
    Uda, Muneaki
    Kanda, Yasunari
    Osada, Tomoharu
    Hayashi, Seiji
    Miyamoto, Norimasa
    Kasai, Chieko
    Tashibu, Hiroyuki
    Inutsuka, Takashi
    Sugiyama, Atsushi
    Sawada, Kohei
    Sekino, Yuko
    [J]. JOURNAL OF PHARMACOLOGICAL SCIENCES, 2016, 130 (03) : S223 - S223
  • [5] Modeling of cardiac ischaemia and reperfusion injury: a human-based in vitro model using iPS-derived cardiomyocytes
    Pinho, J.
    Scrimgeour, N. R.
    Stolen, T.
    Solvang-Garten, K.
    Sharma, A.
    Fonseca, D. Miranda
    Smith, G.
    Hoydal, M.
    [J]. EUROPEAN HEART JOURNAL, 2017, 38 : 229 - 230
  • [6] In vitro pharmacology and safety testing using human iPS-derived Cor.4U cardiomyocytes
    Kettenhofen, Ralf
    Tressat, Kristina
    Kolossov, Eugen
    Hebeisen, Simon
    Jaehne, Evelyn
    Ehlich, Andreas
    Schwengberg, Silke
    Bohlen, Heribert
    [J]. JOURNAL OF PHARMACOLOGICAL AND TOXICOLOGICAL METHODS, 2013, 68 (01) : E7 - E7
  • [7] Identification of CV liabilities in the xCELLigence system using human iPS-derived cardiomyocytes
    Kazusa, Katsuyuki
    Watanabe, Yudai
    Nagata, Keisuke
    Sato, Yumiko
    Fujimori, Chikara
    Shirakawa, Takafumi
    Okada, Akinobu
    [J]. JOURNAL OF PHARMACOLOGICAL AND TOXICOLOGICAL METHODS, 2016, 81 : 344 - 344
  • [8] Novel imaging-based assay system detecting delayed inhibitory effect on hERG channel using human iPS-derived cardiomyocytes
    Nagakura, Tadashi
    Matsubara, Takayoshi
    Ohashi, Hiromi
    Sawada, Kohei
    Yoshinaga, Takashi
    [J]. JOURNAL OF PHARMACOLOGICAL AND TOXICOLOGICAL METHODS, 2018, 93 : 117 - 118
  • [9] An in vitro assay for assessing cardiac contractility using hiPSC-derived cardiomyocytes and cellular impedance measurement
    Huang, Minxue
    Thalody, George
    Shi, Hong
    Levesque, Paul
    [J]. JOURNAL OF PHARMACOLOGICAL AND TOXICOLOGICAL METHODS, 2013, 68 (01) : E22 - E22
  • [10] A novel in vitro model for evaluating drug-induced QT prolongation using genetically modified human iPS-derived cardiomyocytes
    Li, Min
    Kanda, Yasunari
    Ashihara, Takashi
    Sasano, Tetsuo
    Sekino, Yuko
    Furukawa, Tetsushi
    Kurokawa, Junko
    [J]. JOURNAL OF PHARMACOLOGICAL SCIENCES, 2014, 124 : 86P - 86P
12345